RDTCF (Rapid Dose Therapeutics) FCF Margin %: -428.91% (As of Nov. 2025)

What is Rapid Dose Therapeutics FCF Margin %?

Rapid Dose Therapeutics RDTCF -11.11% 27 FCF Margin % is -428.91% as of Nov. 2025. GuruFocus rates RDTCF with a GF Score™ of 27/100 and a GF Value™ of $0.30 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 947 Biotechnology companies, Rapid Dose Therapeutics ranks worse than 56.07% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Rapid Dose Therapeutics's Free Cash Flow for the three months ended in Nov. 2025 was $-2.00 Mil. Rapid Dose Therapeutics's Revenue for the three months ended in Nov. 2025 was $0.47 Mil. Therefore, Rapid Dose Therapeutics's FCF Margin % for the quarter that ended in Nov. 2025 was -428.91%.

As of today, Rapid Dose Therapeutics's current FCF Yield % is -26.91%.

The historical rank and industry rank for Rapid Dose Therapeutics's FCF Margin % or its related term are showing as below:

RDTCF' s FCF Margin % Range Over the Past 10 Years
Min: -4213.86 Med: -194.91 Max: -55.3
Current: -126.01

During the past 13 years, the highest FCF Margin % of Rapid Dose Therapeutics was -55.30%. The lowest was -4213.86%. And the median was -194.91%.

RDTCF's FCF Margin % is ranked worse than
56.07% of 947 companies
in the Biotechnology industry
Industry Median: -82.65 vs RDTCF: -126.01

Rapid Dose Therapeutics FCF Margin % Related Terms

Rapid Dose Therapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Rapid Dose Therapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rapid Dose Therapeutics FCF Margin % Chart

Rapid Dose Therapeutics Annual Data

Trend

Sep16

Sep17

Sep18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Feb25

FCF Margin %

Get a 7-Day Free Trial

-216.13

-173.51

-120.22

-224.87

-55.28

Rapid Dose Therapeutics Quarterly Data
	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25	Aug25	Nov25
FCF Margin %	Get a 7-Day Free Trial															-52.92	0.64	-55.75	-38.93	-428.91

RDTCF vs VRTX, REGN, ALNY: FCF Margin % Comparison

For the Biotechnology subindustry, Rapid Dose Therapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rapid Dose Therapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rapid Dose Therapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Rapid Dose Therapeutics's FCF Margin % falls into.

Save Embed

27GF Score

Rapid Dose Therapeutics Corp RDTCF

FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Rapid Dose Therapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Rapid Dose Therapeutics's FCF Margin for the fiscal year that ended in Feb. 2025 is calculated as

FCF Margin	=	Free Cash Flow (A: Feb. 2025 )	/	Revenue (A: Feb. 2025 )
	=	-0.806	/	1.458
	=	-55.28 %

Rapid Dose Therapeutics's FCF Margin for the quarter that ended in Nov. 2025 is calculated as

FCF Margin	=	Free Cash Flow (Q: Nov. 2025 )	/	Revenue (Q: Nov. 2025 )
	=	-2.003	/	0.467
	=	-428.91 %

Frequently Asked Questions Learn more about FCF Margin % →

What does a FCF Margin % of -428.91% mean?

Rapid Dose Therapeutics (RDTCF) has a FCF Margin % of -428.91% as of Nov. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Rapid Dose Therapeutics and its competitors. According to the industry distribution chart, Rapid Dose Therapeutics ranks #531 out of 947 companies in the Biotechnology industry, placing it in the top 56.1%.

Is Rapid Dose Therapeutics' FCF Margin % too high?

Rapid Dose Therapeutics' current FCF Margin % is -428.91%. Based on the distribution chart, Rapid Dose Therapeutics ranks #531 out of 947 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Rapid Dose Therapeutics has a GF Score™ of 27/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.

How does Rapid Dose Therapeutics' FCF Margin % compare to VRTX and REGN?

According to the Biotechnology industry distribution chart, Rapid Dose Therapeutics ranks #531 out of 947 companies for FCF Margin %. This places Rapid Dose Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Margin % for a Biotechnology company?

A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Margin % mean?

A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Rapid Dose Therapeutics and its competitors. Rapid Dose Therapeutics's current FCF Margin % is -428.91%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Rapid Dose Therapeutics stock overvalued right now?

Based on GuruFocus' analysis, Rapid Dose Therapeutics (RDTCF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.30, compared to a current price of $0.08 — trading 73.3% below its estimated fair value. The current FCF Margin % is -428.91%. Rapid Dose Therapeutics' overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Margin % calculated?

FCF Margin % is calculated from a company's financial statements. For Rapid Dose Therapeutics (RDTCF), the current FCF Margin % is -428.91% as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rapid Dose Therapeutics (RDTCF) Overvalued in 2026?

Based on GuruFocus' analysis, Rapid Dose Therapeutics stock appears to be undervalued. The current stock price of $0.08 is trading 73.3% below its estimated GF Value™ of $0.30. GuruFocus considers Rapid Dose Therapeutics to be Possible Value Trap.

Key valuation signals for RDTCF:

FCF Margin %: -428.91%
GF Value™: $0.30 vs. price of $0.08 (73.3% below fair value)
GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the RDTCF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rapid Dose Therapeutics Business Description

Industry Healthcare Biotechnology

Comparable Companies XCNQ:BLAB XCNQ:PREV NEOE:BMND TSXV:HEM TSXV:MRVL XCNQ:SKNY TSX:CSCI XCNQ:MDMA XCNQ:GLOW TSXV:KNE VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges DOSE:Canada

Address 1121 Walkers Line, Unit 3a, Burlington, ON, CAN, L7N 2G4

Website https://www.rapid-dose.com

Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, and cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

27GF Score

Get the complete analysis for RDTCF

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08

Price

$0.30

GF Value

View RDTCF Analysis

See FCF Margin % data for all stocks →